结肠癌治疗的发展研究

唐 文涵
西南大学蚕桑纺织与生物质科学学院

摘要

对肿瘤的标准诊断通常基于应用细胞毒性药物，放疗，化疗以及术后，靶向药物在结肠癌的化疗用药和术
前化疗过程中起着关键性作用，能够延长结肠癌病人的生存期，从而改善他们的生存质量。本研究概括了结肠癌靶
向药物疗法的主要靶向药物，及其新型治疗药物的研究进展。

关键词

结肠癌；药物治疗；靶向位点

参考

[1] 丁志海，靶向药物治疗转移性结肠癌的研究进

展 %J 医疗装备 .2018.31（06）：p.203-204.

[2] 杨波，et al.，结肠癌及其分型的靶分子修饰递

送药物的研究进展 %J 中国药房 .2019.30（18）：p.2577-

2582.

[3]Yamagishi, H., et al., Molecular pathogenesis of

sporadic colorectal cancers. Chin J Cancer, 2016. 35: p. 4.

[4]Schell, M.J., et al., A multigene mutation classification

of 468 colorectal cancers reveals a prognostic role for APC. Nat

Commun, 2016. 7: p. 11743.

[5]Pandurangan, A.K., et al., Colorectal carcinogenesis:

Insights into the cell death and signal transduction pathways: A

review. World J Gastrointest Oncol, 2018. 10(9): p. 244-259.

[6] 向琳 and 彭金兰，抗肿瘤新药——贝伐单抗 %J 医

药导报 %J HERALD OF MEDICINE. 2006. 25(10): p. 1087-

1088.

[7]Garcia, J., et al., Bevacizumab (Avastin®) in cancer

treatment: A review of 15 years of clinical experience and

future outlook. Cancer Treatment Reviews, 2020. 86: p.

102017.

[8]Chen, M., et al., The epidermal growth factor receptor

(EGFR) is proteolytically modified by the Matriptase-Prostasin

serine protease cascade in cultured epithelial cells. Biochim

Biophys Acta, 2008. 1783(5): p. 896-903.

[9]Cerea, G., et al., Cetuximab for treatment of metastatic

colorectal cancer. Annals of Oncology, 2006. 17: p. vii66-

vii67.

[10]Chen, R., et al., Modulation of the tumour

microenvironment in hepatocellular carcinoma by tyrosine

kinase inhibitors: from modulation to combination therapy

targeting the microenvironment. Cancer Cell Int, 2022. 22(1): p.

73.

[11]Zhao, P., et al., Dual-targeting biomimetic

delivery for anti-glioma activity via remodeling the tumor

microenvironment and directing macrophage-mediated

immunotherapy. Chem Sci, 2018. 9(10): p. 2674-2689.

[12] 王 嘉 源 and 董 卫 国， 结 肠 癌 靶 向 治 疗 研 究

Targeted therapy for colon cancer %J 胃肠病学和肝病学杂

志 %J Chinese Journal of Gastroenterology and Hepatology.

2020. 29(7): p. 721-725.